Residual Neuromuscular Blockade in the Critical Care Setting

AACN Advanced Critical Care
Nicole Stawicki, Patty Gessner

Abstract

Residual neuromuscular blockade is a widespread challenge for providers in the acute care setting that, if left unrecognized or untreated, places patients at higher risk for morbidity and mortality. The condition is estimated to occur in 26% to 88% of patients undergoing general anesthesia. The role of the advanced practice nurse in the acute care setting is to facilitate a safe recovery process by identifying early signs of deterioration and supporting the patient until full muscular strength has returned. This article discusses the prevalence of residual neuromuscular blockade and associated complications and patient risk factors. A review is included of the current uses for neuromuscular blockade, pathophysiology of the neuromuscular junction, pharmacologic characteristics of neuromuscular blocking agents (including drug-drug interactions), monitoring modalities, and effectiveness of reversal agents. Treatment recommendations pertinent to residual neuromuscular blockade are outlined.

References

Nov 1, 1970·British Journal of Anaesthesia·H H AliC Gray
Feb 5, 2008·The Journal of Emergency Medicine·Robert McNamara, Michael J Mihalakis
Feb 18, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sean P KeenanUNKNOWN Canadian Critical Care Trials Group/Canadian Critical Care Society Noninvasive Ventilation Guidelines Group
Jun 5, 2012·Critical Care Nurse·Jason WilsonBrea O Rowan
Apr 10, 2013·Current Infectious Disease Reports·Judith Barash
May 11, 2013·Anaesthesia and Intensive Care·S PhillipsA B Bilgin
Jul 24, 2013·Anaesthesiology Intensive Therapy·Piotr Pietraszewski, Tomasz Gaszyński
Dec 23, 2014·Current Anesthesiology Reports·Hassan FarhanMatthias Eikermann
Jan 23, 2016·Expert Opinion on Pharmacotherapy·Friederike Haerter, Matthias Eikermann
Jul 2, 2016·Turkish Journal of Anaesthesiology and Reanimation·Dilek Yazıcıoğlu ÜnalOnur Özlü
Oct 19, 2016·Critical Care Medicine·Michael J MurraySangeeta Mehta
Feb 12, 2017·British Journal of Anaesthesia·A Miskovic, A B Lumb
Apr 13, 2017·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Eric Shih Hsiung LeeAddy Yong Hui Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.